12-Week Open-Label Extension Study of TNX-102 SL in PTSD Patients
Public ClinicalTrials.gov record NCT03110575. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 12-Week Open-Label Extension Study to Evaluate TNX-102 SL Taken Daily at Bedtime in Patients With PTSD
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is an open-label, extension trial designed to evaluate safety over 12 additional weeks of TNX-102 SL therapy taken daily at bedtime for the treatment of PTSD. Patients recruited into this trial are those who have successfully completed the double-blind lead-in study.
Study identification
- NCT ID
- NCT03110575
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 190 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 19, 2017
- Primary completion
- Jul 26, 2018
- Completion
- Jul 26, 2018
- Last update posted
- Feb 5, 2025
2017 – 2018
United States locations
- U.S. sites
- 32
- U.S. states
- 15
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Phoenix | Phoenix | Arizona | 85032 | — |
| Rogers | Rogers | Arkansas | 72758 | — |
| Beverly Hills | Beverly Hills | California | 90210 | — |
| Glendale | Glendale | California | 91206 | — |
| Oakland | Oakland | California | 94607 | — |
| Oceanside | Oceanside | California | 92056 | — |
| Orange | Orange | California | 92868 | — |
| Riverside | Riverside | California | 92506 | — |
| San Diego | San Diego | California | 92123 | — |
| San Diego | San Diego | California | 92161 | — |
| Temecula | Temecula | California | 92591 | — |
| Colorado Springs | Colorado Springs | Colorado | 80910 | — |
| Jacksonville | Jacksonville | Florida | 32256 | — |
| Lake City | Lake City | Florida | 32607 | — |
| Lauderhill | Lauderhill | Florida | 33319 | — |
| Tampa | Tampa | Florida | 33609 | — |
| Atlanta | Atlanta | Georgia | 30341 | — |
| New Bedford | New Bedford | Massachusetts | 02740 | — |
| Flowood | Flowood | Mississippi | 39232 | — |
| Las Vegas | Las Vegas | Nevada | 89102 | — |
| Berlin | Berlin | New Jersey | 08009 | — |
| Cedarhurst | Cedarhurst | New York | 11516 | — |
| New York | New York | New York | 10128 | — |
| Canton | Canton | Ohio | 44718 | — |
| Cincinnati | Cincinnati | Ohio | 45219 | — |
| Dayton | Dayton | Ohio | 45417 | — |
| Oklahoma City | Oklahoma City | Oklahoma | 73103 | — |
| Charleston | Charleston | South Carolina | 29407 | — |
| Austin | Austin | Texas | 78754 | — |
| Dallas | Dallas | Texas | 75231 | — |
| Houston | Houston | Texas | 77098 | — |
| San Antonio | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03110575, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 5, 2025 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03110575 live on ClinicalTrials.gov.